ADD CONDITION

items per page

Jianze Sting Relief Pads

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 6 g/100 g
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2012
Label revision date
June 20, 2012
Active ingredient
Benzocaine 6 g/100 g
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2012
Label revision date
June 20, 2012
Manufacturer
Changzhou Jianze Sanitary Material Co. , Ltd.
Registration number
part348
NDC root
50666-008

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

JIANZE STING RELIEF PADS are designed to provide temporary relief from pain and itching caused by minor burns, scrapes, and insect bites. These pads can be a helpful option for soothing specific minor skin irritations, allowing you to feel more comfortable while your skin heals.

Uses

You can use this medication for temporary relief of pain and itching caused by minor burns, scrapes, and insect bites. It helps soothe discomfort and allows you to feel more comfortable while your skin heals.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication, making it a safer option for use.

Dosage and Administration

You can apply this medication to the affected area up to 3 to 4 times a day. It is suitable for both adults and children who are 2 years old or older. If you have a child under 2 years of age, it's important to consult a physician (doctor) before using this medication. Always follow these guidelines to ensure safe and effective use.

What to Avoid

It's important to be aware of specific instructions regarding the use of this medication. You should not use it in your eyes. If the medication accidentally comes into contact with your eyes, make sure to flush them with water immediately to avoid irritation or damage.

Currently, there are no listed contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. Always follow the guidance provided by your healthcare professional to ensure safe and effective use.

Side Effects

When using this product, it's important to remember that it is for external use only. Additionally, it is flammable, so be sure to keep it away from any flames or heat sources to avoid any accidents. Always prioritize your safety while using this product.

Warnings and Precautions

This product is for external use only, so please avoid ingesting it. It is also flammable, so keep it away from any flames or heat sources to prevent fire hazards.

If you accidentally swallow this product, seek emergency medical help immediately or contact a Poison Control Center for assistance. It's important to act quickly in such situations to ensure your safety.

While there are no specific instructions to stop using the product, always consult your doctor if you have any concerns or experience unusual symptoms. Your health and safety are paramount, so don’t hesitate to reach out for professional advice.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health.

Pregnancy Use

When it comes to using this medication during pregnancy, there is currently no information available about its safety, recommended dosage adjustments, or any special precautions you should take. This means that if you are pregnant or planning to become pregnant, it is essential to consult with your healthcare provider before starting or continuing this medication. They can help you weigh the potential risks and benefits based on your individual situation. Always prioritize open communication with your doctor to ensure the best care for you and your baby.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to be aware that there is no specific information available regarding the effects of this medication on nursing mothers or lactation (the process of producing breast milk). Since there are no guidelines or data provided, it’s advisable to consult your healthcare provider for personalized advice and to discuss any potential risks or concerns related to your situation. Your healthcare provider can help you make informed decisions that prioritize both your health and your baby's well-being.

Pediatric Use

This medication is suitable for adults and children who are 2 years old and older. If your child is under 2 years of age, it’s important to consult a physician (a medical doctor) before using this medication.

Always keep this medication out of reach of children. If a child accidentally swallows it, seek medical help immediately or contact a Poison Control Center for assistance. Your child's safety is a top priority, so please follow these guidelines carefully.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on renal impairment. However, it’s always best to consult with your healthcare provider about your kidney health and any medications you are taking. They can provide personalized advice and ensure that your treatment is safe and effective for you.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help determine the best course of action based on your individual situation.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, every individual is different, and your healthcare provider can help ensure that your treatment is safe and effective for you. Always feel free to ask questions and share your complete list of medications and tests during your appointments.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally between 15°C and 30°C (59°F to 86°F). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, make sure to do so in a clean environment to avoid contamination. Always follow any specific instructions provided for use and disposal to ensure safety and effectiveness.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years or older. If the patient is under 2 years old, it's important to consult a physician before use. There are no additional details available regarding laboratory tests, abuse potential, or postmarketing experiences related to this medication.

FAQ

What is JIANZE STING RELIEF PADS used for?

JIANZE STING RELIEF PADS are used for temporary relief of pain and itching associated with minor burns, scrapes, and insect bites.

How often can I apply JIANZE STING RELIEF PADS?

You can apply JIANZE STING RELIEF PADS to the affected area not more than 3 to 4 times daily.

Who can use JIANZE STING RELIEF PADS?

JIANZE STING RELIEF PADS are for adults and children 2 years of age or older. Consult a physician for children under 2 years.

Are there any contraindications for using JIANZE STING RELIEF PADS?

No contraindications are listed for JIANZE STING RELIEF PADS.

What should I do if I accidentally get JIANZE STING RELIEF PADS in my eyes?

If JIANZE STING RELIEF PADS come into contact with your eyes, flush them with water immediately.

Is JIANZE STING RELIEF PADS flammable?

Yes, JIANZE STING RELIEF PADS are flammable, so keep them away from flames.

What should I do if JIANZE STING RELIEF PADS are swallowed?

If JIANZE STING RELIEF PADS are swallowed, get medical help or contact a Poison Control Center right away.

How should I store JIANZE STING RELIEF PADS?

Store JIANZE STING RELIEF PADS at room temperature between 15 degrees - 30 degrees C (59 degrees - 86 degrees F).

Packaging Info

Below are the non-prescription pack sizes of Jianze Sting Relief Pads (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Jianze Sting Relief Pads.
Details

Drug Information (PDF)

This file contains official product information for Jianze Sting Relief Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

JIANZE STING RELIEF PADS are provided in a count of 200 pads per package, with the product identified by the code 50666-008-01. The effective date of this formulation is June 14, 2012. The product is visually represented by two images: an inner image labeled "StingReliefPadsInner" and an outer image labeled "StingReliefPadsOuter," both in JPEG format.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor burns, scrapes, and insect bites.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied to the affected area no more than 3 to 4 times daily. It is indicated for use in adults and children aged 2 years and older. For children under 2 years of age, consultation with a physician is recommended prior to use.

Contraindications

Use is contraindicated in the eyes. In the event of contact with the eyes, it is essential to flush the eyes with water immediately.

Warnings and Precautions

For external use only. This product is flammable; it should be kept away from flames and other sources of ignition to prevent fire hazards.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center without delay. Prompt action is crucial to ensure the safety and well-being of the patient.

Healthcare professionals are advised to monitor patients closely and to instruct them to discontinue use and consult their physician if any adverse reactions occur, even though specific instructions for cessation were not provided in the available information.

Side Effects

Patients should be aware that the product is for external use only. It is important to note that the product is flammable; therefore, it should be kept away from flames to prevent any potential hazards.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond these warnings. However, users are advised to exercise caution and follow the instructions for use to minimize any risks associated with the product.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Jianze Sting Relief Pads (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Jianze Sting Relief Pads.
Details

Pediatric Use

Pediatric patients aged 2 years and older may use this medication. For children under 2 years of age, consultation with a physician is advised prior to use.

It is important to keep this medication out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine safety and efficacy in this population.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of specific antidotes or treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to seek medical help or contact a Poison Control Center immediately if the product is swallowed. It is important for patients to understand the potential risks associated with ingestion and the need for prompt action.

Additionally, healthcare providers should instruct patients on the appropriate steps to take in the event of eye contact. Patients should be informed to flush their eyes with water thoroughly if contact occurs, emphasizing the importance of rinsing to minimize any potential irritation or damage.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at room temperature, within the range of 15 degrees to 30 degrees Celsius (59 degrees to 86 degrees Fahrenheit). Care should be taken to ensure that the product is kept in a suitable container to maintain its integrity during storage.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, consultation with a physician is advised. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Jianze Sting Relief Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Jianze Sting Relief Pads, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.